KAY LEWIS: Open Payments
NPI 1447278668 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 34 payments from 5 companies in 2025. Trend: 2023 $1,542 · 2024 $934 · 2025 $1,336
Food & beverage: $1,234Education: $101
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $331 |
| Teva Pharmaceuticals USA, Inc. | 14 | $317 |
| E.R. Squibb & Sons, L.L.C. | 5 | $310 |
| Janssen Pharmaceuticals, Inc | 5 | $260 |
| Neurocrine BioSciences, Inc. | 1 | $118 |
Products named: INVEGA SUSTENNA, ARISTADA, COBENFY, UZEDY, BREYANZI, INGREZZA, LYBALVI, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
